Compare HBCP & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HBCP | QTRX |
|---|---|---|
| Founded | 1908 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.0M | 160.0M |
| IPO Year | 2008 | 2017 |
| Metric | HBCP | QTRX |
|---|---|---|
| Price | $66.26 | $3.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $65.50 | $6.00 |
| AVG Volume (30 Days) | 42.0K | ★ 863.7K |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | ★ 29.01 | N/A |
| EPS | ★ 2.93 | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | $3.97 | $10.04 |
| P/E Ratio | $22.65 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $50.54 | $2.15 |
| 52 Week High | $74.50 | $8.77 |
| Indicator | HBCP | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.24 | 67.24 |
| Support Level | $64.88 | $3.31 |
| Resistance Level | $71.28 | $3.65 |
| Average True Range (ATR) | 1.28 | 0.22 |
| MACD | -0.21 | 0.11 |
| Stochastic Oscillator | 3.97 | 93.21 |
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.